Bhargavaea cecembensis

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Bhargavaea cecembensis is a Gram-positive, non-spore-forming, aerobic, non-motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 59.5%. Bhargavaea cecembensis is unlikely to be a gut coloniser. (Verma2012; Manorama2009)



  • This organism has been recovered from deep sea sediment. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • GENERAL CHARACTERISTICS (Verma2012); (Manorama2009);
    Character Response
  • Substrates hydrolysed or digested:
  • urea;
  • 🧂
  • Salt tolerance:
  • tolerates 6% salt;
  • pH
  • Acidity tolerance:
  • Grows optimally at pH 7-7.5.
  • 🌡
  • Temperature tolerance:
  • grows at 15℃; grows at 55℃; Grows optimally at 37℃.
  • ⥅
  • Substrates assimilated or utilised:
  • adonitol; fructose; maltose; melezitose; arginine; proline;
  • Active enzymes:
  • catalase; lipase; oxidase; urease;
    • SPECIAL FEATURES (Verma2012); (Manorama2009);
    Character Response
  • ✓
  • Metabolites produced:
  • Hâ‚‚S;
  • ✗
  • Metabolites not produced:
  • indole;
  • ✗
  • VP test:
  • not active
  • ✓
  • NO3➔NO2:
  • reduced
    • RESPONSE TO ANTIBIOTICS (Verma2012); (Manorama2009);
    Class Active Resistant
  • Penicillins:
  • ampicillin; carbenicillin; penicillin G;
  • Cephalosporins:
  • cefotaxime;
  • cefazolin;
  • Macrolides:
  • erythromycin; oleandomycin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • ciprofloxacin; norfloxacin;
  • nalidixic-acid;
  • Aminoglycosides:
  • amikacin; gentamicin; kanamycin; spectinomycin; tobramycin;
  • Polypep/ketides:
  • bacitracin; rifampicin;
  • Heterocycles:
  • chloramphenicol; nitrofurantoin;
  • co-trimoxazole;
  • Vancomycins:
  • vancomycin;
  • Miscellaneous antibiotics:
  • novobiocin;
  • lincomycin; colistin; polymyxin B;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Bacillales Family:  Planococcaceae Genus:  Bhargavaea Gram stain:  + O2 Relation.:  aerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  deep sea sediment
    DNA G+C(%):  59.5
    Opt. T:  37℃
    Low T(℃):  15(+)
    High T(℃):  55(+)
    NaCl >6%:  6(+)
    Opt. pH:  7-7.5
    		Aesculin:  neg Urea:  + Gelatin:  neg Starch:  neg Tyrosine:  neg Tween:  60(+) 80(neg)
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  neg Fructose:  neg Galactose:  neg Glucose:  neg Mannose:  neg Rhamnose:  neg Xylose:  neg Lactose:  neg Maltose:  neg Sucrose:  neg Trehalose:  neg Adonitol:  neg Dulcitol:  neg Erythritol:  neg Inositol:  neg Mannitol:  neg Sorbitol:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Arabinose:  neg L-Arabinose:  neg Fructose:  + Galactose:  neg Glucose:  neg Mannose:  neg Rhamnose:  neg Ribose:  neg Sorbose:  neg Xylose:  neg Cellubiose:  neg Lactose:  neg Maltose:  + Melezitose:  + Melibiose:  neg Raffinose:  neg Sucrose:  neg Trehalose:  neg N_Acetyl_glucosamine:  neg Adonitol:  + Arbutin:  neg Dulcitol:  neg Gluconate:  neg Glycerol:  neg Inositol:  neg Inulin:  neg Mannitol:  neg Me-α-D-Glc:  neg Salicin:  neg Sorbitol:  neg Xylitol:  neg Ala:  neg D-Ala:  neg Arg:  + Asp:  neg Cys:  neg Glu:  neg Gly:  neg His:  neg Ile:  neg Leu:  neg Lys:  neg Met:  neg Orn:  neg Phe:  neg Pro:  + Ser:  neg Thr:  neg Trp:  neg Tyr:  neg Val:  neg Acetate:  neg Citrate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  + Urease:  + β-Galactosidase:  neg ArgDH:  neg LysDC:  neg OrnDC:  neg TrpAA:  neg Lipase:  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  + Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  S(10; disc)
    carbenicil:  S(100; disc)
    penicillin_G:  S(10; disc)
    cefazolin:  R(30; disc)
    cefotaxime:  S(30; disc)
    amikacin:  S(30; disc)
    gentamicin:  S(30; disc)
    kanamycin:  S(30; disc)
    spectinomycin:  S(100; disc)
    tobramycin:  S(10; disc)
    erythromycin:  S(15; disc)
    oleandomycin:  S(15; disc)
    ciprofloxacin:  S(5; disc)
    nalidixic-acid:  R(30; disc)
    norfloxacin:  S(10; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(30; disc)
    vancomycin:  S(30; disc)
    bacitracin:  S(10; disc)
    rifampicin:  S(30; disc)
    chloramphenicol:  S(30; disc)
    nitrofurantoin:  S(300; disc)
    co-trimoxazole:  R(25; disc)
    lincomycin:  R(2; disc)
    novobiocin:  S(30; disc)
    colistin:  R(10; disc)
    polymyxin_B:  R(50U)

    References

    SPECIFIC REFERENCES FOR BHARGAVAEA CECEMBENSIS
  • Verma2012 - Reclassification of Bacillus beijingensis Qiu et al. 2009 and Bacillus ginsengi Qiu et al. 2009 as Bhargavaea beijingensis comb. nov. and Bhargavaea ginsengi comb. nov. and emended description of the genus Bhargavaea.
  • Manorama2009 - Bhargavaea cecembensis gen. nov., sp. nov., isolated from the Chagos-Laccadive ridge system in the Indian Ocean.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BHARGAVAEA CECEMBENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
    • Added: January 14, 2022